Central nervous system injury from novel cancer immunotherapies
Publication
, Journal Article
Winter, SF; Vaios, EJ; Dietrich, J
Published in: Current Opinion in Neurology
December 2020
Duke Scholars
Published In
Current Opinion in Neurology
DOI
EISSN
1473-6551
ISSN
1350-7540
Publication Date
December 2020
Volume
33
Issue
6
Start / End Page
723 / 735
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Winter, S. F., Vaios, E. J., & Dietrich, J. (2020). Central nervous system injury from novel cancer immunotherapies. Current Opinion in Neurology, 33(6), 723–735. https://doi.org/10.1097/wco.0000000000000867
Winter, Sebastian F., Eugene J. Vaios, and Jorg Dietrich. “Central nervous system injury from novel cancer immunotherapies.” Current Opinion in Neurology 33, no. 6 (December 2020): 723–35. https://doi.org/10.1097/wco.0000000000000867.
Winter SF, Vaios EJ, Dietrich J. Central nervous system injury from novel cancer immunotherapies. Current Opinion in Neurology. 2020 Dec;33(6):723–35.
Winter, Sebastian F., et al. “Central nervous system injury from novel cancer immunotherapies.” Current Opinion in Neurology, vol. 33, no. 6, Ovid Technologies (Wolters Kluwer Health), Dec. 2020, pp. 723–35. Crossref, doi:10.1097/wco.0000000000000867.
Winter SF, Vaios EJ, Dietrich J. Central nervous system injury from novel cancer immunotherapies. Current Opinion in Neurology. Ovid Technologies (Wolters Kluwer Health); 2020 Dec;33(6):723–735.
Published In
Current Opinion in Neurology
DOI
EISSN
1473-6551
ISSN
1350-7540
Publication Date
December 2020
Volume
33
Issue
6
Start / End Page
723 / 735
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences